Original Contributions. Family History in Patients With Transient Ischemic Attacks
|
|
- Marlene Lyons
- 5 years ago
- Views:
Transcription
1 Original Contributions 83 Family History in Patients With Transient Ischemic Attacks Lawrence M. Brass, MD, and Laurie A. Shaker, MS To determine the influence of family history on vascular disease, we surveyed hospital patients discharged with a diagnosis of transient ischemic attack. Of respondents, 81 knew their family history for myocardial infarction and 81 knew their family history for stroke. Of 83 responding 43 reported a personal history of myocardial infarction, and of 85 responding reported a personal history of stroke. As expected, there was an association between positive family and personal histories of myocardial infarction in younger (aged <0 years) patients (Fisher's two-tailed exact test, p=0.014). This association was reversed for stroke (Fisher's two-tailed exact test, p=0.01). Older (aged >0 years) patients had a stronger association between positive family and personal histories of stroke; 14 (4) of 19 older patients with a positive personal history of stroke had a positive family history of stroke. The reason for this reversal in the relation between family and personal histories of stroke compared with myocardial infarction may relate to the older age at onset of most strokes, differing stroke subtypes in older age groups, or lower rates of fatal myocardial infarction. This study suggests that familial factors may be important in some subtypes of cerebrovascular disease. Familial effects may be different in vascular diseases of the heart and brain. (Stroke 1991;:83-841) Downloaded from by on October, 018 A ssessment of risk factors in different races, / \ sexes, and age groups can provide important J. \. clues to the pathogenesis of cerebrovascular disease and provide direction for the development of preventive strategies. Strong familial risk factors, both genetic and environmental, have been implicated in coronary artery disease (CAD), especially in younger patients. 1 Although strokes, both ischemic and hemorrhagic, have been observed to cluster in families, few studies have examined familial risks. 3 Given the possible implications for preventive therapies, we began preliminary investigations into the familial risk of stroke in a high-risk population. Subjects and Methods To select a group at high risk for stroke, we surveyed all patients with a discharge diagnosis of transient ischemic attack (TLA) from Yale-New Haven Hospital, New Haven, Conn., for a 4-year period (January 1985-January 1989). Using the hospital's From the Departments of Neurology (L.M.B.) and Epidemiology and Public Health (L.A.S.), Yale University School of Medicine, New Haven, Conn. Presented in part at the 4nd Annual Meeting of the American Academy of Neurology, Miami Beach, Fla., May Supported in part by gifts to the Yale Stroke Program. Address for correspondence: Lawrence M. Brass, MD, Yale Stroke Program, Department of Neurology, LCI-00, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 05. Received September 14, 1990; accepted March 18, Clinical Information System, patients were identified using the International Classification of Diseases coding for TIA as either a primary or secondary discharge diagnosis. A questionnaire was developed as part of a Department of Epidemiology project on risk factor modification after TIA. The questionnaire included information on personal and family histories of both myocardial infarction (MI) and stroke, as well as on common vascular risk factors. A positive family history was defined as a "yes" response to the question, "Has anyone in your immediate family (blood relative) had an Ml/stroke/hypertension/diabetes?" Specific information on which family members were affected was not required, but nearly all patients responding to a subsequent question indicated that the family member affected was a parent (approximately 5), aunt or uncle (approximately ), grandparent (approximately ), or sibling (approximately ). After an initial mailing, nonrespondents were telephoned and a second questionnaire was sent. Only "yes" and "no" responses were used; blanks, "don't know," and "unsure" were excluded from the calculations. Age 0 years was used as the division point between older and younger patients because it was near the median age of our population (yielding sufficient numbers in each age category to permit examination of the association between family history and personal history in both younger and older patients).
2 838 Stroke Vol, July 1991 TABLE 1. Associations Between Personal and Family Histories of Myocardiai Infarction and Stroke Family history MI Stroke Personal history.. P.. P MI All ages <0yr yr Stroke All ages <0yr MI, myocardiai infarction. Downloaded from by on October, 018 This age was also clinically sensible because it is similar to the division points reported in previous studies of vascular disease.i Statistical analysis of the association between suspected risk factors and a history of MI or stroke was performed using x contingency tables. Fisher's two-tailed exact test was used for all calculations. Calculations were performed using SAS Version (SAS Institute Inc., Cary, N.C.). Results Review of the hospital's data bank identified 94 admissions; 00 (8) had TIA as a primary diagnosis and the other 94 () had TLA as a secondary diagnosis. Five patients had died during their hospital stay. For 8, the complete medical record could not be located. There were 13 duplicate names on the list. The initial cohort consisted of the remaining 48 patients. There were 1 women and 1 men. The median age was 9 (range 14-99) years. Of the 48 questionnaires mailed, 8 (33) of the patients had died since discharge, 1 () were unable to complete the survey due to disability (e.g., severe aphasia, dementia), six () had no forwarding address and could not be located, and () declined participation. Of the 1 patients alive at the time of the survey, (0) responded. For personal history, 83 (1) of the patients answered the question on MI and 43 (5) reported a positive personal history, 85 (3) of the patients answered the question on stroke and (8) reported a positive personal history. For hypertension, 59 of 93 responding (3) reported a positive personal history; for diabetes, 15 of 8 responding (18) reported a positive personal history. For family history, 81 (9) of the patients answered the question on MI and 5 (0) were positive; 81 (9) of the patients answered the question on stroke and 3 (4) were positive. Of those responding, 55 of 8 (1) had a positive family history of hypertension and 5 of 1 (35) had a positive family history of diabetes. Sixty-six people answered both the personal and family history questions for MI with a definite yes or no; answered both questions for stroke. When a family history of MI was tested with a personal history of MI for all ages, there was no significant association (Table 1). Of the people who responded to both MI questions, 38 were younger than age 0 years. In these younger patients, there was a significant association between family history and personal history of MI: 1 (0) of 1 patients with a positive personal history of MI had a positive family history of MI compared with seven of () with neither (p=0.014). For older patients there was no significant association. The influence of a family history of MI on a personal history of stroke (Table 1) was also examined ( people answered both questions). There was a significant association found across the entire co-
3 Downloaded from by on October, 018 hort, regardless of age; 38 (9) of 48 patients with a positive personal history of stroke had a positive family history of MI compared with nine of 18 () with neither (/?=0.0). When we examined the association of a family history of stroke with a personal history of stroke (Table 1), there was no significant association for the entire cohort. However, when the relation between family history and personal history of stroke was examined within different age categories, a significant association was found. In contrast to MI, the positive association was found in older patients. For the 8 older patients answering both stroke questions, 14 of 19 (4) with a positive personal history of stroke had a positive family history of stroke compared with seven of nine (8) with neither (p=0.01). For the 39 younger patients, of (34) with a positive personal history of stroke also had a positive family history of stroke compared with three of seven (43) with neither (/>=0.40). A family history of stroke was not associated with a personal history of MI in the younger patients, the older patients, or the entire cohort (Table 1). Discussion To define a cohort at high risk for stroke, we studied patients admitted to the hospital after a TIA. Risk in this group represents a diagnostic, prognostic, and therapeutic challenge and influenced our selection of the study design and patient cohort. A control group of patients without symptomatic cerebrovascular disease may be useful for subsequent studies. Such a control group may have helped clarify the results in this study. Although we had a high response rate of eligible patients, the persons who did not respond to the survey or those not certain about their family history could have influenced our results. Other potential biases should also be noted. There may be considerable variability in reporting a diagnosis, especially in a family member. Also, our cohort consisted of patients with physician-diagnosed TLA, but there may be significant disagreement in this diagnosis, even among neurologists. 1 It is possible that our cohort included patients with deficits that cleared after 4 hours, but this may be of little consequence because TLA and minor stroke appear to have similar recurrence rates, mortality, 13 and risk factors. 14 The prevalence of comorbid diseases in our cohort was much higher than in population-based studies. 14 The majority of patients reported a stroke, raising concern about whether our cohort should be viewed as a TIA cohort. The mortality rate was also significantly higher in our cohort than in others Patients with TTAs admitted to the hospital (i.e., included in our study) may represent a sicker group. 1 This effect may be even greater in New Haven, which has traditionally been very conservative about cerebrovascular disease. 18 Many neurologists in this community do not admit patients with "uncomplicated" TIAs. Brass and Shaker Family History in a TIA Cohort 839 Lastly, our responding patients survived 1-4 years after their TLA. Our results may therefore represent a familial influence on survival after a stroke. Survival varies with stroke subtype 19 ; a similar effect is likely to occur after TIA. It is possible that stroke survival cohorts, like ours, have a higher percentage of patients with small-vessel disease because of the higher mortality associated with large-vessel disease. 0 We may be noting a familial influence on a particular stroke subtype. Subgroup analyses to look for possible explanations for the above associations were attempted (e.g., familial associations of vascular risk factors), but cell sizes were too small for meaningful calculations. Small cell sizes also limit statistical power. The lack of demonstration of a difference in this setting is not equivalent to the absence of an effect. Twin and family history studies have provided strong evidence that familial and genetic factors are important, especially in early-onset CAD Estimating the contribution of established risk factors, familial environmental factors, or genetic attributes has been controversial. ' However, it does appear as if, after correcting for traditional risk factors, having a first-degree relative with premature CAD is, by itself, a significant risk factor. 3 These studies support the association with family history seen in our younger patients with MI. A positive family history of MI was also associated with stroke in both age categories in our study. Although the numbers were small, the association was significant. A similar association has been described in women. 4 In our cohort, a positive family history of stroke did not predict MI, an association described by others. 5 Few studies have investigated the genetic and familial contributions to cerebrovascular disease. 3 Most studies have been very limited in their classification of stroke and have relied on a patient's recollection or death certificates for family history. The results have been mixed. Gifford found excessive death from cerebrovascular disease among parents and relatives of stroke patients. The diagnosis of stroke included thrombosis, embolism, and hemorrhage. Alter found higher disease rates in siblings (1-fold) and parents (threefold) of stroke patients than in controls. Our study also included a variety of stroke subtypes. Heyden et al 8 compared the mortality patterns in parents of patients with severe carotid occlusive disease undergoing internal carotid endarterectomy and the parents of controls with vascular and nonvascular disease. The parents of patients with carotid disease had higher rates of death from vascular disease (any cause) than did parents of either control group, but patients in the control groups had significantly lower rates of hypertension. Hypertension is known to have a strong familial component. It is possible that familial clustering of risk factors accounted for all or part of this association.
4 Downloaded from by on October, Stroke Vol, July 1991 A recent investigation addresses this point. Welin et al 9 found a threefold increase in the incidence of stroke among middle-aged men whose mothers had died of stroke. There was no difference with respect to vascular risk factors, including blood pressure, between this group and a group without maternal death from stroke. The etiologic fraction for maternal death from stroke was 0.19, nearly as strong a risk as systolic hypertension (0.3). Howard and colleagues 30 noted that the risk of death from stroke varies considerably among families of stroke patients. These workers examined the risk of death from stroke or CAD in children of stroke patients. Most families had low risk, but a few demonstrated a strong familial tendency, which was most strongly correlated with a parental history of diabetes and a young parental age at first stroke. Those results, although demonstrating an age association opposite to ours, may have measured a different aspect of vascular risk factors, predisposition to stroke, or survival after stroke. Several studies have failed to demonstrate a genetic contribution to stroke. 31 " 33 The overall conclusions are equivocal. The World Health Organization Task Force on Stroke and Other Cerebrovascular Disorders 34 concluded that genetic or familial factors have not yet been demonstrated to be an important risk factor for stroke. In our study, the effect of age and family history on cerebrovascular disease was opposite that for cardiac disease. The reason for this is not clear. It is possible that we were measuring a familial tendency for recurrent stroke, but most of the known risk factors associated with recurrent stroke appear to be the same as those for first stroke: age, cardiac comorbidity, diabetes, and hypertension.,035-3 It is also possible that we are seeing an effect on survival after stroke, but long-term survival after infarction is also influenced by many of the factors associated with the occurrence of stroke. These factors include hypertension, advanced age, and cardiac comorbidity. 3 ' 38 It is possible that these risks interact with each other and with familial or genetic factors to account for our findings. Age is important in interpreting the risk of a family history for vascular disease; which parent is affected may also contribute. Scholdkraut et al 9 noted an association between coronary risk and parental history of death by CAD. The effect was strongest in young patients with CAD (both parents contributed to risk), but in those older than age 0 years only maternal death from CAD was a strong predictor. The relative importance of vascular risk factors for stroke also appears to vary with age and sex. 39 Hypertension, blood pressure, left ventricular hypertrophy, smoking, and hematocrit appear to have strong associations with stroke in younger patients (<5 years old). Diabetes appears to be a strong factor for stroke in women. Increased serum lipids have generally not been associated with an increased risk of stroke, except in men <0 years old. 40 Serum cholesterol, a strong risk factor for ischemic cardiac disease, does not have a strong predictive value in the elderly, although the usual risk is still associated with low density lipoprotein and high density lipoprotein cholesterol. 41 In addition, carotid stenosis appears to be correlated with hypercholesterolemia, but in the elderly this association may not be as strong. 4 Alter et al 43 demonstrated an age-dependence of vascular risk factors for recurrent stroke (MI, hypertension, diabetes), but in their cohort there was a stronger association in the older age groups. Information from the Stroke Data Bank 44 suggests that the prevalence of stroke and most likely TLA subtype varies with age. Our results may represent a familial influence on a single stroke subtype. In summary, our data suggest that age is an effect modifier 45 in the relation between personal and family histories of both stroke and MI. Age is also generally acknowledged to act as a confounder in vascular disease, 4 but with our limited sample sizes we were unable to assess this reliably. The best and most cost-effective approach to cerebrovascular disease is prevention. The first lines of defense in stroke prevention are the detection and management of risk factors. 39 There may be some debate whether familial risks can be modified. Studies on CAD suggest that they can. It may be that the effect of risk modification is greater in familial disease than in the general population. For example, Khaw and Barrett estimated that 8 of excess deaths in men with a family history of heart attack were attributable solely to the interaction of family history with smoking habits and are therefore potentially avoidable. Thus, the risk of vascular disease associated with an inherited predisposition may be profoundly affected by modifiable behavior. Further examination of the genetic and familial contributions to stroke risk may permit the development of interventions in lifestyle and diet at an early age, when preventive measures may have the greatest impact. 4 This work raises important questions not only in the genetic contribution to stroke, but also in vascular risk factors in the elderly. Studies addressing risk factors for vascular disease in the elderly are difficult tofind,even for cardiac disease. The few studies that exist suggest that there may be important differences Although potential selection biases may exist, our study suggests that different familial factors play a role in at least some subgroups of stroke. Age, important in familial cardiac disease, may be important in cerebrovascular disease, but the associated risks may not be identical. Acknowledgments We would like to acknowledge the students who participated in "A Survey of TIA Diagnosed Patients: The Psychosocial and Demographic Issues in the Awareness of Risk Factor Reduction and Behavior Modification" as part of the Epidemiology and Public Health Course 5a-Spring 1989; Adrian Ostfeld, MD; and Elaine Anderson, MPH.
5 Downloaded from by on October, 018 References 1. Goldbourt U, Neufeld HN: Genetic aspects of arteriosclerosis. Arteriosclerosis 198;:35-3. Galton DJ: Molecular genetics of coronary heart disease. Adv Exp Med Biol 1988;43: Alberts MJ: Genetics of cerebrovascular disease. Stroke 1990; (suppl III):III-1-IIM30 4. Deutscher S, Ostrander LD, Epstein FH: Familial factors in premature coronary heart disease: A preliminary report from the Tecumseh Community Health Study. Am J Epidemiol 190;91: Thelle DS, Forde OH: The cardiovascular study in Finnmark County: Coronary risk factors and the occurrence of myocardial infarction in first degree relatives and in subjects of different ethnic origins. Am J Epidemiol 199;1: Ten Kate LP, Boman H, Daiger SP, Motulsky AG: Familial aggregation of coronary heart disease and its relation to known genetic risk factors. Am J Cardiol 198;: Khaw KT, Barrett CE: Family history of heart attack: A modifiable risk factor? Circulation 198;4: Berg K: Twin studies of coronary heart disease and its risk factors. Ada Genet Med Gemellol (Roma) 198;3: Scholdkraut JM, Myers RH, Cupples LA, Liely DK, Kannel WB: Coronary risk associated with age and sex of parental heart disease in the Framingham study. Am J Cardiol 1989;4: Kernan WN, Horowitz RI, Brass LM, Viscoli CM, Taylor KJW: A prognostic system for patients with TIA or minor stroke. Ann Intern Med 1991;4: Harlow SD, Linet MS: Agreement between questionnaire data and medical records: The evidence for accuracy of recall. / Epidemiol 1989;19: Kraaijeveld CL, van Gijn J, Schouln HJA, Staal A: Interobserver agreement for the diagnosis of transient ischemic attacks. Stroke 1984;15: Wiebers D, Whisnant J, O'Fallon W: Reversible ischemic neurologic deficit (RIND) in a community: Rochester, Minnesota, (abstract). Neurology 1981;31(suppl ):1 14. Dennis MS, Bamford JM, Sandercock PAG, Warlow CP: A comparison of risk factors and prognosis for transient ischemic attacks and minor ischemic strokes: The Oxfordshire Community Stroke Project. Stroke 1989;0: Muuronen A, Kaste M: Outcome of 314 patients with transient ischemic attacks. Stroke 198;13: Falke P, Stavenow L, Young M, Lindgarde F: Differences in mortality and cardiovascular morbidity during a 3-year follow-up of transient ischemic attacks and minor strokes. Stroke 1989;0: Whisnant JP, Cartlidge NEF, Elveback LR: Carotid and vertebral-basilar transient ischemic attacks: Effect of anticoagulants, hypertension, and cardiac disorders on survival and stroke occurrence: A population study. Ann Neurol 198;3: Wenenberg JE, Freeman JL, Culp WJ: Are hospital services rationed in New Haven or over-utilised in Boston? Lancet 198;1: Sacco RL, Mohr JP, Hauser WA: Predictors of one year outcome in 30-day survivors of cerebral infarction (abstract). Ann Neurol 1989;:15 0. Petty GW, Tatemichi TK, Sacco RL, Owen J, Mohr JP: Fatal or severely disabling cerebral infarction during hospitalization for stroke or transient ischemic attack. / Neurol 1990;3: Perkins KA: Family history of coronary heart disease: Is it an independent risk factor? Am J Epidemiol 198;14: Goldbourt U: Family history of coronary heart disease: Is it an independent risk factor? Am J Epidemiol 198;1: Berg K: Genetics of coronary heart disease and its risk factors. Prog Clin Biol Res 1985;1: Thompson SG, Greenberg G, Meade TW: Risk factors for stroke and myocardial infarction in women in the United Brass and Shaker Family History in a TIA Cohort 841 Kingdom as assessed in general practice: A case-control study. Br Heart J 1989;1: Khaw KT, Barrett CE: Family history of stroke as an independent predictor of ischemic heart disease in men and stroke in women. Am J Epidemiol 198;13:59-. Gifford AJ: An epidemiological study of cerebrovascular disease. Am J Public Health 19;5: Alter M: Genetic factors in cerebrovascular accidents. Trans Am Neurol Assoc 19;9: Heyden S, Heyman A, Camplong L: Mortality patterns among parents of patients with atherosclerotic cerebrovascular disease. / Chronic Dis 199;: Welin L, Svardsudd K, Wilhelmsen L, Larsson B, Tibblin G: Analysis of risk factors for a stroke cohort of men born in N Engl J Med 198;31: Howard G, Evans EW, Toole JF, Tell G, Rose LA, Espeland M, Truscott BL: Characteristics of stroke victims associated with early- cardiovascular mortality in their children. J Clin Epidemiol 1990;43: Alter M, Klvjznik J: Genetics of cerebrovascular accidents. Stroke 19;3: Marshall J: Familial incidence of cerebral hemorrhage. Stroke 193;4: Herman B, Schmitz PI, Leyten AC, Van Luijk JH, Frenken CW, De Coul AA, Schulte BP: Multivariate logistic analysis of risk factors for stroke in Tilburg, The Netherlands. Am J Epidemiol 1983;8: WHO Task Force on Stroke and Other Cerebrovascular Disorders: Stroke 1989: Recommendations on stroke prevention, diagnosis, and therapy. Stroke 1989;0: Howard G, Evans GW, Murros KE, Toole JF, Lefkowitz D, Truscott BL: Cause specific mortality following cerebral infarction. / Clin Epidemiol 1989;4: Sobel E, Alter M, Davanipour Z, Friday G, McCoy R, Levitt LP, Isack T: Stroke in the Lehigh Valley: Combined risk factors for recurrent stroke. Neurology 1989;39:9-3. Robins M, Weinfeld FD: The National Survey of Stroke: Survey evaluation. Stroke 1981;1:I3-I Chambers BR, rris JW, Shurvell BL, Hachinski VC: Prognosis of acute stroke. Neurology 198;3: Wolf PA, Kannel WB: Reduction of stroke through risk factor modification. Semin Neurol 198;: Kannel WB, Gordon T, Dawber TR: Role of lipids in the development of brain infarction: The Framingham Study. Stroke 194;5: Kannel WB, Gordon T: Evaluation of cardiovascular risk in the elderly: The Framingham Study. Bull N Y Acad Med 198;54: Aronow WS, Gutstein H, Lee NH, Edwards M: Three year follow-up of risk factors correlated with new atherothrombotic brain infarction in 08 elderly patients. Angiology 1988;39: Alter M, Sobel E, McCoy RL, Francis ME, Davaipour Z, Shofer F, Levitt LP, Meehan EF: Stroke in the Lehigh Valley: Risk factors for recurrent stroke. Neurology 198;3:3-44. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB: The Stroke Data Bank: Design, methods, and baseline characteristics. Stroke 1988;19: Miettinen OS: Confounding and effect modification. Am J Epidemiol 1984;0: Ostfeld AM: A review of stroke epidemiology. Epidemiol Rev 1980;: Puska P: Possibilities of a preventative approach to coronary heart disease starting in childhood. Ada Paediatr Scand Suppl 1985;318: Castelli WP, Wilson PWF, Levy D, Anderson K: Cardiovascular risk factors in the elderly. Am J Cardiol 1989;3: 1H-19H KEY WORDS cardiovascular diseases cerebrovascular disorders cerebral ischemia, transient risk factors
Risk Factors for Ischemic Stroke: Electrocardiographic Findings
Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead
More informationOriginal Contributions. Prospective Comparison of a Cohort With Asymptomatic Carotid Bruit and a Population-Based Cohort Without Carotid Bruit
98 Original Contributions Prospective Comparison of a Cohort With Carotid Bruit and a Population-Based Cohort Without Carotid Bruit David O. Wiebers, MD, Jack P. Whisnant, MD, Burton A. Sandok, MD, and
More informationThe Impact of Smoking on Acute Ischemic Stroke
Smoking The Impact of Smoking on Acute Ischemic Stroke Wei-Chieh Weng, M.D. Department of Neurology, Chang-Gung Memorial Hospital, Kee-Lung, Taiwan Smoking related mortality Atherosclerotic vascular disease
More informationCerebrovascular disease is a major medical problem in the
Long-Term Mortality in Cerebrovascular Disease Dawn M. Bravata, MD; Shih-Yieh Ho, PhD; Lawrence M. Brass, MD; John Concato, MD; Jeanne Scinto, PhD, MPH; Thomas P. Meehan, MD, MPH Background and Purpose
More informationIt is generally accepted that hypertension is associated
1605 Hypertension and Risk of Stroke Recurrence Milton Alter, MD, PhD; Gary Friday, MD; Sue Min Lai, PhD; John O'Connell, MD; Eugene Sobel, PhD Background and Purpose Hypertension is a risk factor for
More informationRedgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on
6. Imaging in TIA 6.1 What type of brain imaging should be used in suspected TIA? 6.2 Which patients with suspected TIA should be referred for urgent brain imaging? Evidence Tables IMAG1: After TIA/minor
More informationThere is no gold standard for the diagnosis of
1220 Original Contributions Silent Stroke in Patients With Transient Ischemic Attack or Minor Ischemic Stroke D. Herderschee, MD; A. Hijdra, MD; A. Algra, MD; P.J. Koudstaal, MD; L.J. Kappelle, MD; and
More informationAPPENDIX A NORTH AMERICAN SYMPTOMATIC CAROTID ENDARTERECTOMY TRIAL
APPENDIX A Primary Findings From Selected Recent National Institute of Neurological Disorders and Stroke-Sponsored Clinical Trials That Have shaped Modern Stroke Prevention Philip B. Gorelick 178 NORTH
More informationNatural History of Stroke in Rochester, Minnesota, 1955 Through 1969: An Extension of a Previous Study, 1945 Through 1954
Natural History of Stroke in Rochester, Minnesota, Through : An Extension of a Previous Study, Through BY NOBUTERU MATSUMOTO, M.D./ JACK P. WHISNANT, M.D., LEONARD T. KURLAND, M.D., AND HARUO OKAZAKI,
More informationTransient Ischemic Attacks and Risk of Stroke in an Elderly Poor Population
Transient Ischemic Attacks and Risk of Stroke in an Elderly Poor Population BY A. M. OSTFELD, M.D., R. B. SHEKELLE, Ph.D., AND H. L. KLAWANS, M.D. Abstract: Transient Ischemic A t tacks and Risk of Stroke
More informationClinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease
Cronicon OPEN ACCESS EC NEUROLOGY Research Article Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Jin Ok Kim, Hyung-IL Kim, Jae Guk Kim, Hanna Choi, Sung-Yeon
More informationSupplementary webappendix
Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Hart RG, Diener H-C, Coutts SB, et al,
More informationThe Importance of Family History in Cerebrovascular Disease
1599 The Importance of Family History in Cerebrovascular Disease Carmelo Graffagnino, MD, FRCPC; Andrew P. Gasecki, MD; Gordon S. Doig, MD; Vladimir C. Hachinski, MD, FRCPC, MSc, DSc(Med) Background and
More informationEffect of Medicine Adherence on the Occurrence of Cerebrovascular Disorders in Diabetes Mellitus Patients
Epidemiology and Health Epidemiology and Health Volume: 33, Article ID: e2011001, 6 pages DOI 10.4178/epih/e2011001 ORIGINAL ARTICLE Effect of Medicine Adherence on the Occurrence of Cerebrovascular Disorders
More informationAndrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION
2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL
More informationStroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%
Stroke Update Michel Torbey, MD, MPH, FAHA, FNCS Medical Director, Neurovascular Stroke Center Professor Department of Neurology and Neurosurgery The Ohio State University Wexner Medical Center Objectives
More informationTennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center
Tennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center 2006 Tennessee Department of Health 2006 ACKNOWLEDGEMENTS CONTRIBUTING
More informationRehospitalization for Stroke among Elderly TIA Patients
Rehospitalization for Stroke among Elderly TIA Patients By William Buczko, PhD Centers for Medicare & Medicaid Services 7500 Security Blvd. C3-19-07 Baltimore, MD 21244-1850 Email: WBuczko@CMS.HHS.gov
More informationStroke is the third-leading cause of death and a major
Long-Term Mortality and Recurrent Stroke Risk Among Chinese Stroke Patients With Predominant Intracranial Atherosclerosis Ka Sing Wong, MD; Huan Li, MD Background and Purpose The goal of this study was
More informationFamily history of heart attack: a modifiable risk
PATHOPHYSIOLOGY AND NATURAL HISTORY CORONARY ARTERY DISEASE Family history of heart attack: a modifiable risk factor? KAY-TEE KHAW, M.Sc., M.R.C.P., AND ELIZABETH BARRETT-CONNOR, M.D. ABSTRACT A family
More informationEmergency Department Stroke Registry Process of Care Indicator Specifications (July 1, 2011 June 30, 2012 Dates of Service)
Specifications Description Methodology NIH Stroke Scale (NIHSS) Performed in Initial Evaluation used to assess the percentage of adult stroke patients who had the NIHSS performed during their initial evaluation
More informationSpeakers. 2015, American Heart Association 1
Speakers Lee Schwamm, MD, FAHA Executive Vice Chairman of Neurology, Massachusetts General Hospital Director, Stroke Service and Medical Director, MGH TeleHealth, Massachusetts General Hospital Director,
More informationStroke patients constitute an increasing challenge
236 Outcome After Stroke in Patients Discharged to Independent Living Margareta Thorngren, MD, Britt Westling, MD, and Bo Norrving, MD In a prospective, population-based study, we evaluated rehabilitation
More informationMORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance
MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1
More informationHow would you manage Ms. Gold
How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56
More informationHigh Density Lipoprotein Cholesterol and Mortality
High Density Lipoprotein Cholesterol and Mortality The Framingham Heart Study Peter W.F. Wilson, Robert D. Abbott, and William P. Castelli In 12 years of follow-up for 2748 Framingham Heart Study participants
More informationThree months prognosis of transient ischemic attack (TIA) in Erbil Governorate
Three months prognosis of transient ischemic attack (TIA) in Erbil Governorate Received: 26/12/2012 Accepted: 12/6/2013 Introduction A transient ischemic attack (TIA) is a brief episode of neurological
More informationAntithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)
Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase
More informationA trial fibrillation (AF) is a common arrhythmia that is
679 PAPER Atrial fibrillation as a predictive factor for severe stroke and early death in 15 831 patients with acute ischaemic stroke K Kimura, K Minematsu, T Yamaguchi, for the Japan Multicenter Stroke
More informationSlide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure
Slide 1 The Treatment of Intracranial Stenosis Helmi Lutsep, MD Vice Chair and Dixon Term Professor, Department of Neurology, Oregon Health & Science University Chief of Neurology, VA Portland Health Care
More informationMORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance
MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1
More informationThe secondary prevention of ischemic stroke is aided by the use of antiplatelet therapy,
NEUROLOGICAL REVIEW SECTION EDITOR: DAVID E. LEASURE, MD Results of the Management of Atherothrombosis With Clopidogrel in High-Risk atients Trial Implications for the Neurologist Marc Fisher, MD The secondary
More informationRacial Variations in Ischemic Stroke-Related Physical and Functional Impairments
1497 Racial Variations in Ischemic Stroke-Related Physical and Functional Impairments Ronnie D. Horner, PhD; David B. Matchar, MD; George W. Divine, PhD; and John R. Feussner, MD Background and Purpose:
More informationStroke is the third leading cause of death in the
Probability of Stroke: A Risk Profile From the Framingham Study Philip A. Wolf, MD; Ralph B. D'Agostino, PhD; Albert J. Belanger, MA; and William B. Kannel, MD A health risk appraisal function has been
More informationNational public health campaigns have attempted
WINTER 2005 PREVENTIVE CARDIOLOGY 11 CLINICAL STUDY Knowledge of Cholesterol Levels and Targets in Patients With Coronary Artery Disease Susan Cheng, MD; 1,2 Judith H. Lichtman, MPH, PhD; 3 Joan M. Amatruda,
More informationCritical Review Form Therapy
Critical Review Form Therapy A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects, Lancet-Neurology 2007; 6: 953-960 Objectives: To evaluate the effect of
More informationPeripheral Arterial Occlusive Disease- The Challenge in patients with diabetes
Peripheral Arterial Occlusive Disease- The Challenge in patients with diabetes Ashok Handa Reader in Surgery and Consultant Surgeon Nuffield Department of Surgery University of Oxford Introduction Vascular
More informationDoes quality of life predict morbidity or mortality in patients with atrial fibrillation (AF)?
Does quality of life predict morbidity or mortality in patients with atrial fibrillation (AF)? Erika Friedmann a, Eleanor Schron, b Sue A. Thomas a a University of Maryland School of Nursing; b NEI, National
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Berry JD, Dyer A, Cai X, et al. Lifetime risks of cardiovascular
More informationSeveral studies have suggested that short-term stroke risk
Poststroke Neurological Improvement Within 7 Days Is Associated With Subsequent Deterioration Stella Aslanyan, MD; Christopher J. Weir, PhD; S. Claiborne Johnston, MD, PhD; Kennedy R. Lees, MD, FRCP; for
More informationDyslipidemia in the light of Current Guidelines - Do we change our Practice?
Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dato Dr. David Chew Soon Ping Senior Consultant Cardiologist Institut Jantung Negara Atherosclerotic Cardiovascular Disease
More informationCurrent role of low molecular weight heparin in the treatment of acute. ischemic stroke.
International Journal of Advances in Medicine Singh K. Int J Adv Med. 2017 Dec;4(6):1599-1604 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20175174
More informationAtherosclerotic Disease Risk Score
Atherosclerotic Disease Risk Score Kavita Sharma, MD, FACC Diplomate, American Board of Clinical Lipidology Director of Prevention, Cardiac Rehabilitation and the Lipid Management Clinics September 16,
More informationStroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013
Stroke 101 Maine Cardiovascular Health Summit Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013 Stroke Statistics Definition of stroke Risk factors Warning signs Treatment
More informationTHE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease
THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS 1. Cardiovascular Disease Cardiovascular disease is considered to have developed if there was a definite manifestation
More informationDr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre
Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre Objectives To learn what s new in stroke care 2010-11 1) Acute stroke management Carotid artery stenting versus surgery for symptomatic
More information4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for
+ Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics
More informationJUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012
SAMUEL TCHWENKO, MD, MPH Epidemiologist, Heart Disease & Stroke Prevention Branch Chronic Disease & Injury Section; Division of Public Health NC Department of Health & Human Services JUSTUS WARREN TASK
More informationChapter. Absolute risk of venous and arterial thrombosis in HIV-infected patients and effects of combination antiretroviral therapy
Chapter Absolute risk of venous and arterial thrombosis in HIV-infected patients and effects of combination antiretroviral therapy Willem M. Lijfering Min Ki ten Kate Herman G. Sprenger Jan van der Meer
More informationComparison of Probability of Stroke Between the Copenhagen City Heart Study and the Framingham Study
80 Comparison of Probability of Stroke Between the Copenhagen City Heart Study and the Framingham Study Thomas Truelsen, MB; Ewa Lindenstrtfm, MD; Gudrun Boysen, DMSc Background and Purpose We wished to
More informationNicolas Bianchi M.D. May 15th, 2012
Nicolas Bianchi M.D. May 15th, 2012 New concepts in TIA Differential Diagnosis Stroke Syndromes To learn the new definitions and concepts on TIA as a condition of high risk for stroke. To recognize the
More informationR acial differences in pathology of the intracranial
Duplex Doppler and Spectral Flow Analysis of Racial Differences in Cerebrovascular Atherosclerosis A. GU-Peralta, MD, M. Alter, MD, PhD, S.M. Lai, MS, G. Friday, MD, A. Otero, RN, M. Katz, BS, and A.J.
More informationDiabetologia 9 Springer-Verlag 1991
Diabetologia (1991) 34:590-594 0012186X91001685 Diabetologia 9 Springer-Verlag 1991 Risk factors for macrovascular disease in mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease
More informationDr Joan Leighton. Professor Gerry Devlin. 14:00-14:55 WS #106: Whats Topical in Cardiology 15:05-16:00 WS #116: Whats Topical in Cardiology (Repeated)
Professor Gerry Devlin Clinical Cardiologist and Interventional Cardiologist NZ Heart Foundation Hamilton Dr Joan Leighton General Practitioner Heart Foundation Christchurch 14:00-14:55 WS #106: Whats
More informationPrognostic studies in stroke medicine focus on the risks of
Cause of Is Multifactorial Patterns, Risk Factors, and Outcomes of in the South London Stroke Register Thomas Hillen, MD, MPH; Catherine Coshall, MSc; Kate Tilling, PhD; Anthony G. Rudd, FRCP; Rory McGovern,
More informationAntiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.
Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.Κιλκίς Primary CVD Prevention A co-ordinated set of actions,
More informationUpdate on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines
Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Paul Mahoney, MD Sentara Cardiology Specialists Lipid Management in Cardiovascular Disease
More informationIt is accepted by a broad consensus that a blood pressure
Control of Hypertension and Risk of Stroke Recurrence Gary Friday, MD, MPH; Milton Alter, MD, PhD; Sue-Min Lai, PhD, MS Background and Purpose We investigated whether low blood pressure increases the risk
More informationInformant Interview Form Instructions (IFI) Version C 05/05/2014
Informant Interview Form Instructions (IFI) Version C 05/05/2014 I. GENERAL INSTRUCTIONS The purpose of the informant interview is to obtain information about possible CHD events in order to classify cause
More informationDUKECATHR Dataset Dictionary
DUKECATHR Dataset Dictionary Version of DUKECATH dataset for educational use that has been modified to be unsuitable for clinical research or publication (Created Date and Time: 28OCT16 14:35) Table of
More informationEpidemiologic and clinical comparison of renal artery stenosis in black patients and white patients
ORIGINAL ARTICLES Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients Andrew C. Novick, MD, Safwat Zald, MD, David Goldfarb, MD, and Ernest E. Hodge, MD,
More informationDeclaration of conflict of interest. None to declare
Declaration of conflict of interest None to declare Risk management of coronary artery disease Arrhythmias and diabetes Hercules Mavrakis Cardiology Department Heraklion University Hospital Crete, Greece
More informationGame Strategy: High Intensity Statin in Stroke. K.M. Osei MD, MSc Cardiovascular Conference PARMC Feb 24, 2018
Game Strategy: High Intensity Statin in Stroke K.M. Osei MD, MSc Cardiovascular Conference PARMC Feb 24, 2018 No Disclosures Are you Mind Full or Mindful? Objectives 1. Discuss the correlation between
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bucholz EM, Butala NM, Ma S, Normand S-LT, Krumholz HM. Life
More informationRisk Factors of Carotid Stenosis in First-Ever Ischemic Stroke in Taiwan: A Hospital-based Study
237 Risk Factors of Carotid Stenosis in First-Ever Ischemic Stroke in Taiwan: A Hospital-based Study Chien-Hung Chang, Yeu-Jhy Chang, Tsong-Hai Lee, Kai-Cheng Hsu, and Shan-Jin Ryu Abstract- Objective:
More information2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
Measure #260: Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2) National Quality Strategy Domain: Patient Safety
More informationStroke/Carotid Artery Disease Outcome Detail (Form 121/132, CaD ppts)
This file contains outcomes collected through the end of Ext1. ID WHI Participant Common ID Col#1 N Missing 0 ASCSOURCE Ascertainment Source Col#2 1 Local Form 121 241 14.9 2 Central Form 121 112 6.9 3
More informationEmergently? Michigan Institute for Neurological Disorders. Garden City Hospital, Garden City, Michigan
Why Should TIA be Treated Emergently? Anne M. Pawlak, D.O. F.A.C.N. Michigan Institute for Neurological Disorders Director Neurology Residency Program, Garden City Hospital, Garden City, Michigan According
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Xian Y, Liang L, et al. Association of intracerebral hemorrhage among patients taking non vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital
More informationStroke/Carotid Artery Disease Outcome Detail (Form 121/132)
In Ext2 these outcomes are only adjudicated for Medical Record Cohort (MRC) ppts. ID WHI Participant Common ID Col#1 ASCSOURCE Ascertainment Source Col#2 1 Local Form 121 1,112 14.4 2 Central Form 121
More information2. Morbidity. Incidence
2. Morbidity This chapter reports on country-level estimates of incidence, case fatality and prevalence of the following conditions: myocardial infarction (heart attack), stroke, angina and heart failure.
More information<INSERT COUNTRY/SITE NAME> All Stroke Events
WHO STEPS STROKE INSTRUMENT For further guidance on All Stroke Events, see Section 5, page 5-15 All Stroke Events Patient Identification and Patient Characteristics (I 1) Stroke
More information5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016
Outpatient Stroke Management Sheila Smith MD May 5, 2016 1 Management of Outpatient Stroke Objectives Review blood pressure management post stroke Review antithrombotic therapy Review statin therapy Discuss
More informationSession : Why do stroke patients need a cardiologist? PREVALENCE OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CEREBRAL INFARCTION
Session : Why do stroke patients need a cardiologist? PREVALENCE OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CEREBRAL INFARCTION The Asymptomatic Myocardial Ischemia in Stroke and Atherosclerotic Disease
More informationJoshua A. Beckman, MD. Brigham and Women s Hospital
Peripheral Vascular Disease: Overview, Peripheral Arterial Obstructive Disease, Carotid Artery Disease, and Renovascular Disease as a Surrogate for Coronary Artery Disease Joshua A. Beckman, MD Brigham
More informationDR as a Biomarker for Systemic Vascular Complications
DR as a Biomarker for Systemic Vascular Complications Lihteh Wu MD Asociados de Mácula, Vítreo y Retina de Costa Rica San José, Costa Rica LW65@cornell.edu Disclosures Dr Wu has received lecture fees from
More informationHow to Choose Between Carotid Stenting and Carotid Endarterectomy for Stroke Prevention
How to Choose Between Carotid Stenting and Carotid Endarterectomy for Stroke Prevention Christopher J. White MD, MSCAI Chief of Medical Services, Professor and Chairman of Medicine Ochsner Medical Center
More informationPsychological Factors and Cardiac Risk and Impact of Exercise Training Programs A Review of Ochsner Studies
The Ochsner Journal 7:167 172, 2007 facademic Division of Ochsner Clinic Foundation Psychological Factors and Cardiac Risk and Impact of Exercise Training Programs A Review of Ochsner Studies Carl J. Lavie,
More informationCanadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management
Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Reorganization of Recommendations 2008 2006 RECOMMENDATIONS: 2008 RECOMMENDATIONS:
More informationEmergency Department Stroke Registry Indicator Specifications 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates)
2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates) Summary of Changes I62.9 added to hemorrhagic stroke ICD-10-CM diagnosis code list (table 3) Measure Description Methodology Rationale Measurement
More informationGuidelines on cardiovascular risk assessment and management
European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine
More informationManagement of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근
Management of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근 Case (2011, 5) 74-years old gentleman Exertional chest pain Warfarin with good INR control Ex-smoker, social(?)
More informationStrokes in young adults are relatively uncommon;
Stroke in Young Adults Heather Bevan, MD, Khema Sharma, MD, and Walter Bradley, DM, FRCP Strokes in young adults are uncommon and often a diagnostic challenge. A retrospective study of strokes due to intracerebral
More informationThe Framingham Coronary Heart Disease Risk Score
Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although
More informationDiabetes Mellitus: A Cardiovascular Disease
Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular
More informationChapter 4: Cardiovascular Disease in Patients With CKD
Chapter 4: Cardiovascular Disease in Patients With CKD The prevalence of cardiovascular disease is 68.8% among patients aged 66 and older who have CKD, compared to 34.1% among those who do not have CKD
More informationRaluca Pavaloiu et al. - Clinical, Epidemiological and Etiopathogenic Study of Ischemic Stroke
Original Paper Clinical, Epidemiological and Etiopathogenic Study of Ischemic Stroke RALUCA PAVALOIU 1, L. MOGOANTA 2 1 Department of Neurology, Hospital of Neuropsychiatry Craiova, Romania 2 Department
More informationNQF ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: The Joint Commission Only CMS Voluntary Only
Last Updated: Version 4.4a NQF ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Set: Stroke (STK) Set Measure ID #: Measure Information Form Collected For: The Joint Commission Only CMS
More informationDo Not Cite. Draft for Work Group Review.
Defect Free Acute Inpatient Ischemic Stroke Measure Bundle Measure Description Percentage of patients aged 18 years and older with a diagnosis of ischemic stroke OR transient ischemic attack who were admitted
More informationIschemic Stroke in Critically Ill Patients with Malignancy
Ischemic Stroke in Critically Ill Patients with Malignancy Jeong-Am Ryu 1, Oh Young Bang 2, Daesang Lee 1, Jinkyeong Park 1, Jeong Hoon Yang 1, Gee Young Suh 1, Joongbum Cho 1, Chi Ryang Chung 1, Chi-Min
More informationHigh density lipoprotein cholesterol and longevity.
Journal of Epidemiology and Community Health, 1987, 42, 60-65 High density lipoprotein cholesterol and longevity. ANCEL KEYS From the Division of Epidemiology, School of Public Health, University of Minnesota,
More informationA: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups
A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were
More informationChapter 4: Cardiovascular Disease in Patients with CKD
Chapter 4: Cardiovascular Disease in Patients with CKD The prevalence of cardiovascular disease (CVD) was 65.8% among patients aged 66 and older who had chronic kidney disease (CKD), compared to 31.9%
More informationORIGINAL INVESTIGATION. New Transient Ischemic Attack and Stroke
ORIGINAL INVESTIGATION New Transient Ischemic Attack and Stroke Outpatient Management by Primary Care Physicians Larry B. Goldstein, MD; John Bian, MS; Gregory P. Samsa, PhD; Arthur J. Bonito, PhD; Linda
More informationTIA SINGOLO E IN CRESCENDO: due diversi scenari della rivascolarizzazione urgente carotidea
TIA SINGOLO E IN CRESCENDO: due diversi scenari della rivascolarizzazione urgente carotidea R. Pini, G.L. Faggioli, M. Gargiulo, E. Pisano, A. Pilato, E. Gallitto, C. Mascoli, L.M. Cacioppa, A. Vacirca,
More informationDESCRIPTION: Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2
Measure #260: Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2) National Quality Strategy Domain: Patient Safety
More informationThe risk of MR-detected carotid plaque hemorrhage on recurrent or first-time stroke: a meta-analysis of individual patient data
The risk of MR-detected carotid plaque hemorrhage on recurrent or first-time stroke: a meta-analysis of individual patient data Schindler A 1, Bonati LH 2, Schinner R 1, Altaf N 3, Hosseini AA 3, Esposito-Bauer
More informationStroke Net Grand Round Webinar
Stroke Net Grand Round Webinar Preconditioning the Brain for Stroke Prevention April 4, 2019 Sebastian Koch University of Miami Department of Neurology None Unique challenges in brain conditioning Review
More information